Opportunity Information: Apply for 7200AA22APS00002 02
PROPEL Adapt (Round 2): Promoting Results and Outcomes through Policy and Economic Levers is a USAID discretionary funding opportunity being run as a specific round under an existing worldwide Annual Program Statement (APS). That structure matters because this Round 2 notice is not a stand-alone solicitation; it is an add-on to APS No. 7200AA22APS00002. Applicants are expected to read both the Round 2 call and the full APS on Grants.gov, since the APS contains key requirements, definitions, submission rules, and standard eligibility details that are not repeated in the Round 2 documentation.
Round 2 (identified as 7200AA22APS00002-02) is focused on receiving concept papers that propose work to strengthen the enabling environment for family planning and reproductive health (FP/RH). In practical terms, this is about improving the policy, financing, and broader systems conditions that shape whether FP/RH services are accessible, funded, supported, and sustained. USAID is also explicitly prioritizing efforts that integrate FP/RH with HIV/AIDS services and with maternal and child health (MCH), reflecting an interest in approaches that connect related health services rather than treating them as isolated programs.
A defining feature of this round is the operating context: USAID is looking for concepts designed for shocks and stressors and for fragile settings. This signals that proposals should account for instability and disruption such as conflict, displacement, climate-related events, economic volatility, disease outbreaks, governance challenges, and other conditions that can weaken health systems and limit service continuity. Concepts are therefore expected to be realistic about constraints in fragile environments and to address how policy and economic levers can help countries and communities maintain or restore FP/RH access and integration during crises or prolonged stress.
The anticipated funding instrument is a cooperative agreement, which generally means USAID expects substantial engagement during implementation compared to a standard grant. The activity category is Health, with CFDA listed as 98.001. USAID anticipates making a single award under Round 2, with an award ceiling of up to $40,000,000. The opportunity was created on April 21, 2022, and the original closing date for submissions was May 20, 2022. Eligibility is governed primarily by the full PROPEL APS, while Round 2 includes additional eligibility details specific to this call in its Section III.
In short, this opportunity is seeking targeted concept papers under the broader PROPEL APS umbrella that emphasize policy and economic solutions to improve FP/RH outcomes, strengthen enabling environments, and advance integration with HIV/AIDS and MCH, specifically tailored to fragile settings and situations marked by shocks and ongoing stressors, with USAID expecting one cooperative agreement award up to $40 million.Apply for 7200AA22APS00002 02
- The Agency for International Development in the health sector is offering a public funding opportunity titled "PROPEL Adapt (Round 2): Promoting Results and Outcomes through Policy and Economic Levers" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
- This funding opportunity was created on 2022-04-21.
- Applicants must submit their applications by 2022-05-20. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $40,000,000.00 in funding.
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: PROPEL Adapt (Round 2) - USAID (APS Add-On)
1) What is PROPEL Adapt (Round 2)?
PROPEL Adapt (Round 2), titled "Promoting Results and Outcomes through Policy and Economic Levers," is a USAID discretionary funding opportunity that is being implemented as a specific round under an existing worldwide Annual Program Statement (APS).
2) Is Round 2 a stand-alone funding opportunity?
No. Round 2 is not a stand-alone solicitation. It is an add-on to APS No. 7200AA22APS00002, and it is identified as 7200AA22APS00002-02.
3) What documents should applicants read to understand the full requirements?
Applicants are expected to read both the Round 2 call and the full APS on Grants.gov. The APS contains key requirements, definitions, submission rules, and standard eligibility details that are not repeated in the Round 2 documentation.
4) What type of submission is USAID requesting for Round 2?
Round 2 is focused on receiving concept papers.
5) What is the main focus of the concept papers in Round 2?
Concept papers should propose work that strengthens the enabling environment for family planning and reproductive health (FP/RH), with an emphasis on policy, financing, and broader systems conditions that affect whether FP/RH services are accessible, funded, supported, and sustained.
6) What does "strengthening the enabling environment" mean in this call?
Based on the Round 2 description, it refers to improving the policy, financing, and systems conditions that shape FP/RH service access and sustainability, including how these conditions hold up (or can be improved) during instability and disruption.
7) Is USAID prioritizing integration with other health areas?
Yes. USAID is explicitly prioritizing efforts that integrate FP/RH with HIV/AIDS services and with maternal and child health (MCH).
8) Why is integration across FP/RH, HIV/AIDS, and MCH important in this opportunity?
The Round 2 notice signals a preference for approaches that connect related health services rather than treating them as isolated programs, aligning FP/RH with HIV/AIDS and MCH service delivery and systems.
9) What operating contexts is Round 2 designed for?
This round is explicitly aimed at fragile settings and contexts marked by shocks and stressors, meaning concepts should be designed to function under instability and disruption.
10) What kinds of "shocks and stressors" does the opportunity refer to?
The notice highlights examples such as conflict, displacement, climate-related events, economic volatility, disease outbreaks, and governance challenges, as well as other conditions that can weaken health systems and limit continuity of services.
11) How should applicants address fragile settings in their concepts?
Concepts are expected to be realistic about constraints in fragile environments and to address how policy and economic levers can help maintain or restore FP/RH access and integration during crises or prolonged stress.
12) What funding instrument does USAID anticipate using?
The anticipated funding instrument is a cooperative agreement.
13) What does a cooperative agreement imply for implementation?
A cooperative agreement generally means USAID expects substantial engagement during implementation compared to a standard grant.
14) What is the activity category and CFDA listing for this opportunity?
The activity category is Health, and the CFDA is listed as 98.001.
15) How many awards does USAID expect to make under Round 2?
USAID anticipates making a single award under Round 2.
16) What is the maximum funding amount available?
The award ceiling is up to $40,000,000.
17) When was the opportunity created and when did it close?
The opportunity was created on April 21, 2022. The original closing date for submissions was May 20, 2022.
18) Where is eligibility defined for Round 2?
Eligibility is governed primarily by the full PROPEL APS. Round 2 also includes additional eligibility details specific to this call in Section III of the Round 2 documentation.
19) Where can applicants find the submission rules and standard eligibility details?
Applicants should refer to the full APS on Grants.gov, since it contains the key requirements, definitions, submission rules, and standard eligibility details that are not repeated in the Round 2 notice.
20) What is the overarching goal of the Round 2 concept papers?
The goal is to propose targeted policy and economic solutions to improve FP/RH outcomes, strengthen enabling environments, and advance integration with HIV/AIDS and MCH, specifically tailored to fragile settings and to situations with shocks and ongoing stressors.
Browse more opportunities from the same category: Health
Next opportunity: NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
Previous opportunity: Best Robotics Grant - Robotics Kits
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for 7200AA22APS00002 02
Applicants also applied for:
Applicants who have applied for this opportunity (7200AA22APS00002 02) also looked into and applied for these:
| Funding Opportunity |
|---|
| Demonstration Projects to Promote Use of Interoperable Health Records in Clinical Research (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 019 Funding Number: RFA AG 23 019 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Understanding the role of Gut Immune dysfunction and Gut Microbiome in pathogenesis of Central Nervous System co-morbidities in people living with HIV (R21 Clinical Trial Not Allowed) Apply for RFA MH 22 230 Funding Number: RFA MH 22 230 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Grants for Early Medical/Surgical Specialists Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) Apply for RFA AG 23 031 Funding Number: RFA AG 23 031 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| NIH Directors Early Independence Awards (DP5 Clinical Trial Optional) Apply for RFA RM 22 021 Funding Number: RFA RM 22 021 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| NIAMS Rheumatic Diseases Research Resource-based Centers (P30 - Clinical Trial Not Allowed) Apply for RFA AR 23 002 Funding Number: RFA AR 23 002 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Emergency Awards: HEAL Initiative: Coordinating Center for National Pain Scientists Career Development (R24 Clinical Trial Not Allowed) Apply for RFA NS 22 060 Funding Number: RFA NS 22 060 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders or Alcohol Use Disorder (U01 Clinical Trial Optional) Apply for PAR 22 143 Funding Number: PAR 22 143 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Policy and Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) Healthcare Disparities: Access, Utilization, and Quality (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 024 Funding Number: RFA AG 23 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders or Alcohol Use Disorder (U19 Clinical Trial Optional) Apply for PAR 22 144 Funding Number: PAR 22 144 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Short-term Mentored Career Enhancement Award in Dental, Oral, and Craniofacial Research for Mid-Career and Senior Investigators (K18- Independent Clinical Trial Not Allowed) Apply for PAR 22 121 Funding Number: PAR 22 121 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed) Apply for RFA AI 22 037 Funding Number: RFA AI 22 037 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Educational Hub for Enhancing Diversity in Computational Genomics and Data Science (U24 Clinical Trials Not Allowed) Apply for RFA HG 22 002 Funding Number: RFA HG 22 002 Agency: National Institutes of Health Category: Health Funding Amount: $1,800,000 |
| Competitive Revision Supplements to Existing AHRQ Grants and Cooperative Agreements to Enhance Workforce Diversity in Health Services Research Apply for PA 22 175 Funding Number: PA 22 175 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) Apply for RFA RM 22 020 Funding Number: RFA RM 22 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) Apply for RFA NS 22 071 Funding Number: RFA NS 22 071 Agency: National Institutes of Health Category: Health Funding Amount: $8,250,000 |
| Understanding the Clinical History of Bacterial Sexually Transmitted Infections (STI) to Accelerate Diagnostic and Vaccine Development (R01 Clinical Trial Not Allowed) Apply for RFA AI 22 034 Funding Number: RFA AI 22 034 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed) Apply for PAR 22 184 Funding Number: PAR 22 184 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies For Acute Cerebroprotection- Interventions (U01 Clinical Trial Not Allowed) Apply for RFA NS 22 066 Funding Number: RFA NS 22 066 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Expanding Prevention Strategies for Mental Disorders in Mobile Populations in Humanitarian Crises (R34 Clinical Trial Optional) Apply for RFA MH 22 180 Funding Number: RFA MH 22 180 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| NINDS Interdisciplinary Team Science Grant (RM1 Clinical Trial Optional) Apply for RFA NS 22 036 Funding Number: RFA NS 22 036 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "7200AA22APS00002 02", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.